SEC Insider Transactions from Ence Chuck.

Last updated: 2026-03-14 11:40 UTC | Total transactions: 9

Ence Chuck, CAO and COO of Relmada Therapeutics ($RLMD), made two open market purchases of company shares over the past year, totaling about $403,000. His most recent buy occurred on November 5, 2025. Among nearly 5,000 insiders tracking open market buys, his total ranks 996th, below the average of $1.5 million across 3.3 transactions per person. Chuck reported no open market sales in the last 365 days.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Dec. 12, 2025 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO A Stock Appreciation Rights 828000 $0.00 828,000.0000 33,191,622 9999.99% 2.49%
Nov. 5, 2025 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CAO and COO P Common Stock 136000 $2.20 403,931.0000 33,191,622 50.76% 0.41%
June 26, 2025 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO A Stock Option (right to buy) 400000 $0.00 400,000.0000 30,408,890 9999.99% 1.32%
May 16, 2025 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO P Common Stock 228961 $0.45 267,931.0000 30,408,890 587.53% 0.75%
May 24, 2024 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO J Stock Option (right to buy) 54624 $0.00 82,090.0000 30,132,170 39.95% 0.18%
May 24, 2024 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO A Stock Option (right to buy) 54624 $0.00 136,714.0000 30,132,170 66.54% 0.18%
Jan. 29, 2024 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO P Common Stock 10800 $3.65 10,800.0000 30,099,203 9999.99% 0.04%
Jan. 30, 2024 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO P Common Stock 14500 $3.87 25,300.0000 30,099,203 134.26% 0.05%
Jan. 31, 2024 RELMADA THERAPEUTICS, INC. $RLMD Ence Chuck CA and CO P Common Stock 13670 $4.05 38,970.0000 30,099,203 54.03% 0.05%